Nuro
As filed: NURO · and 9 other spellings across funds
Every mark, and where it comes from
Each row is one fund's own reported figure for 2026-Q3. "Per share" is the reported dollar value divided by the reported share count — nothing else has been done to it. The filing link opens the document the two numbers came from.
| Fund | Instrument | Shares | Value | Per share | % of fund | As of | Filing |
|---|---|---|---|---|---|---|---|
LargeCap Growth Fund I Principal Funds, Inc | Nuro - Series C | 353,308 | $5.3M | $15.10 | 0.09% | 2026-07-31 | 0000898745-26-001010 |
Destinations Large Cap Equity Fund Brinker Capital Destinations Trust | NURO INC SERIES C CONVERTIBLE_ PREFERRED STOCK 0.00000000 | 108,389 | $623,237 | $5.75 | 0.02% | 2026-08-31 | 0001003715-26-003954 |
SA MFS Large Cap Growth Portfolio SUNAMERICA SERIES TRUST | NURO, INC. | 47,284 | $604,762 | $12.79 | 0.09% | 2026-07-31 | 0001410368-26-100775 |
T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | NURO SERIES C CVT PFD STOCK | 20,748 | $313,295 | $15.10 | 0.01% | 2026-08-31 | 0001099263-26-010983 |
Destinations Large Cap Equity Fund Brinker Capital Destinations Trust | NURO INC SERIES D /PREFERRED/ /RESTRICTED/ 0.00000000 | 26,242 | $186,056 | $7.09 | 0.01% | 2026-08-31 | 0001003715-26-003954 |
T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | NURO SERIES C CVT PFD STOCK | 12,058 | $182,076 | $15.10 | 0.01% | 2026-08-31 | 0001099263-26-011054 |
SA MFS Large Cap Growth Portfolio SUNAMERICA SERIES TRUST | NURO SERIES D CVT PFD | 10,245 | $131,034 | $12.79 | 0.02% | 2026-07-31 | 0001410368-26-100775 |
T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | NURO SERIES C CVT PFD STOCK | 7,799 | $117,765 | $15.10 | 0.01% | 2026-08-31 | 0001099263-26-010981 |
Small Cap Growth Fund VALIC Co I | NURO, INC. | 6,234 | $94,133 | $15.10 | 0.02% | 2026-08-31 | 0001410368-26-108898 |
T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | NURO SERIES D CVT PFD STOCK PP | 5,932 | $90,700 | $15.29 | 0.00% | 2026-08-31 | 0001099263-26-010983 |
T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | NURO SERIES D CVT PFD STOCK PP | 3,303 | $50,503 | $15.29 | 0.00% | 2026-08-31 | 0001099263-26-011054 |
T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | NURO SERIES D CVT PFD STOCK PP | 2,102 | $32,140 | $15.29 | 0.00% | 2026-08-31 | 0001099263-26-010981 |
These funds hold 7 different instruments in Nuro. Different preferred series carry genuinely different rights and prices, so part of the spread above is not disagreement about the company — it is the difference between the securities. Compare rows with the same instrument before drawing a conclusion.
Quarter by quarter
The same measurement, repeated. Fund counts move between quarters partly because holdings change and partly because this snapshot reads a bounded sample of filings, so read the medians rather than the changes in coverage.
| Quarter | Median | Range | Spread | Funds | Value held |
|---|---|---|---|---|---|
| 2026-Q3 | $15.10 | $5.75 – $15.29 | 63% | 5 / 4m | $7.8M |
| 2026-Q2 | $15.10 | $5.73 – $15.29 | 63% | 18 / 8m | $249.9M |
Can you actually own any of this?
No public company discloses a stake in Nuro, and no fund we can price holds it. For an investor without accredited status there is no position to take here at all — the marks above are information, not an opportunity. That is a more useful conclusion than it looks: it is the gap that products promising retail "pre-IPO access" are sold into. See which companies do have routes.
How accurate have marks like these been?
Nuro is still private, so nothing here can be scored against a market price yet. What can be scored is the method: 6 companies we covered have since listed. On the 3 of those whose share count did not change on the way to market, the median fund mark came in -38.2% against the first closing price, with a worst absolute miss of 2250%. Marks are consistently conservative and occasionally very wrong. Every graded listing is published, including the ones that make the method look bad.
How to read this without being misled
This is not what a share of Nuro trades at. Funds here hold preferred stock bought in a funding round, and they carry it at what their valuation committee believes it is worth — usually anchored near what they paid. Common stock sold by employees on a secondary market can trade well above or below it. The two numbers answer different questions.
A median is not a consensus. With 5 funds and a 63% spread, the median is a summary of a small sample, not a market price. The table above is the data; the median is a convenience.
Marks lag. The figures are as of 2026-07-31 to 2026-08-31, filed weeks later. A round or a markdown after that date is not in here yet.
You probably cannot buy this. Shares in Nuro are not available to an individual investor on any ordinary brokerage, and the funds above bought theirs in private rounds. A mark is information about what regulated investors think a stake is worth — not a route to owning one.
Learn to read these filings yourself
Seven free lessons on where a private valuation comes from, how wrong they turn out to be, what the public routes really cost, and how a lock-up expiry works. Every figure computed from the same filings as this page.
Snapshot built 2026-11-07 from SEC EDGAR · all covered companies · this company as JSON